NeoCart®

Made from a patient’s own cells, NeoCart® is an investigational cartilage tissue implant to treat certain knee cartilage injuries. The proprietary procedure uses regenerative medicine technology to create hyaline-like cartilage tissue from a patient’s own cells. The NeoCart® investigational study is intended to determine if NeoCart® may potentially result in durable, long-lasting patient response. To generate the NeoCart® cartilage tissue implant, a surgeon first obtains a small sample of normal cartilage from a patient’s knee through a minimally invasive arthroscopy, or “knee scope.” This small tissue sample, or biopsy, is then treated and placed under special conditions that allow for cell growth, organization and tissue formation. This allows the patient’s own cells to form a hyaline-like cartilage tissue implant before being returned to the surgeon for implantation. The implant can be trimmed so that it fits the injury site (like a puzzle piece). Talk with your doctor about potential risks associated with NeoCart®.Caution: New Biologic. Limited by Federal law to investigational use only and is not available for sale.

The NeoCart Clinical Trial was fully enrolled in June 2017 and is no longer enrolling patients.